Jim Simons Emergent Bio Solutions Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 689,647 shares of EBS stock, worth $6.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

689,647

Previous 760,247 9.29%

Holding current value

$6.14 Million

Previous $3.69 Million 19.09%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$4.26 - $6.94 $300,756 - $489,964	-70,600 Reduced 9.29%	689,647 $4.4 Million
Q1 2025 May 14, 2025	BUY	$4.66 - $11.66 $439,904 - $1.1 Million	94,400 Added 14.18%	760,247 $3.69 Million
Q4 2024 Feb 13, 2025	BUY	$7.72 - $11.97 $1.09 Million - $1.69 Million	140,900 Added 26.84%	665,847 $6.37 Million
Q3 2024 Nov 13, 2024	BUY	$5.72 - $14.77 $2.01 Million - $5.19 Million	351,200 Added 202.13%	524,947 $4.38 Million
Q2 2024 Aug 09, 2024	SELL	$1.86 - $6.98 $1.33 Million - $5.01 Million	-717,553 Reduced 80.51%	173,747 $1.18 Million
Q1 2024 May 13, 2024	BUY	$1.5 - $3.41 $516,000 - $1.17 Million	344,000 Added 62.85%	891,300 $2.26 Million
Q4 2023 Feb 13, 2024	BUY	$1.82 - $3.16 $996,086 - $1.73 Million	547,300 New	547,300 $1.31 Million
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $2.74 Million - $5.34 Million	248,900 Added 451.72%	304,000 $3.59 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $801,591 - $1.43 Million	-39,900 Reduced 42.0%	55,100 $1.16 Million
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $7.21 Million - $11.5 Million	-263,000 Reduced 73.46%	95,000 $2.95 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $13.1 Million - $18.7 Million	358,000 New	358,000 $14.7 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $5.35 Million - $7.77 Million	-62,100 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$79.17 - $111.47 $1.42 Million - $2.01 Million	17,996 Added 40.8%	62,100 $5.56 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $27.9 Million - $45.9 Million	-340,520 Reduced 88.53%	44,104 $4.56 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $13 Million - $21.3 Million	-238,377 Reduced 38.26%	384,624 $30.4 Million
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $6.96 Million - $9.7 Million	-141,100 Reduced 18.47%	623,001 $36 Million
Q4 2019 Feb 13, 2020	SELL	$51.21 - $59.06 $11.3 Million - $13 Million	-220,210 Reduced 22.37%	764,101 $41.2 Million
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $14.9 Million - $20.9 Million	-366,200 Reduced 27.12%	984,311 $51.5 Million
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $25.1 Million - $33.8 Million	-627,891 Reduced 31.74%	1,350,511 $65.2 Million
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $18.4 Million - $25.3 Million	382,391 Added 23.96%	1,978,402 $99.9 Million
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $88.8 Million - $117 Million	1,596,011 New	1,596,011 $94.6 Million

Others Institutions Holding EBS

# of Institutions

187

Shares Held

39.4M

Call Options Held

277K

Put Options Held

151K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $444M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account